Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

140

Full text

Free full text

Publication Types

Journal Article

138

Research Support, Non-U.S. Gov't

Review

Randomized Controlled Trial

Systematic Review

Observational Study

Clinical Trial, Phase III

Meta-Analysis

Research Support, N.I.H., Extramural

Comparative Study

Clinical Trial, Phase II

Multicenter Study

Research Support, U.S. Gov't, Non-P.H.S.

Case Reports

Research Support, U.S. Gov't, P.H.S.

Research Support, N.I.H., Intramural

Validation Study

Clinical Trial, Phase I

Scoping Review

Controlled Clinical Trial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2005

2004

2002

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Dengue""[mesh_terms]

140 Results

Searching titles within these results

E-Protein Protonation Titration-Induced Single-Particle Chemical Force Spectroscopy for Microscopic Understanding and pI Estimation of Infectious DENV.

Priyadarshi Satpati, Manorama Ghosal, Tatini Rakshit, Shreya Bhattacharya, Sankar Bhattacharyya, Dulal Senapati

The journal of physical chemistry. B 2024;128(13):3133-3144

Full Text

Abstract

Immunogenicity and safety of tetravalent dengue vaccines: a systematic review of clinical trials.

Lenyn D Montes-Sevilla, Paul E Hernández-Montes, Erick Ramírez-García, Edgar D Guzmán-Ríos, Marco F Flores-Reyes, Gilberto H Acosta-Gutiérrez, Osmara Morales-Hernández, Manuel I Girón-Pérez

Gaceta medica de Mexico 2025;161(3):227-236

Full Text

Abstract

An overview of dengue viral infection circulating in Pakistan.

Liaqat Ali, Zakkia Gul, Asiya Ijaz, Nouman Khalid, Falak Zeb, Samia Afzal, Anayat Ullah, Fazli Subhan, Saeed Ahmed

Journal of vector borne diseases 2022;59(2):109-114

Free Full Text

Abstract

Liver involvement in dengue: A systematic review.

André Cabié, Valentine Campana, Catherine Inizan, Jean-David Pommier, Luce Yemadje Menudier, Muriel Vincent, Marc Lecuit, Xavier De Lamballerie, Myrielle Dupont-Rouzeyrol, Bernadette Murgue

Reviews in medical virology 2024;34(4):e2564

Full Text

Abstract

Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003).

Charissa Borja-Tabora, Delia Yu, Pope Kosalaraksa, Felix Espinoza, Eduardo López-Medina, Lulu Bravo, Luis Rivera, Shibadas Biswal, Xavier Sáez-Llorens, Humberto Reynales, Chukiat Sirivichayakul, Luis Martinez Vargas, Veerachai Watanaveeradej, Reynaldo Dietze, LakKumar Fernando, Pujitha Wickramasinghe, Edson Duarte MoreiraJr, Asvini D Fernando, Dulanie Gunasekera, Kleber Luz, Rivaldo Venâncioda Cunha, Martina Rauscher, Olaf Zent, Mengya Liu, Elaine Hoffman, Inge LeFevre, Vianney Tricou, Derek Wallace, MariaTheresa Alera, Astrid Borkowski

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022;75(1):107-117

Free Full Text

Abstract

Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials.

Michal Juraska, Craig A Magaret, Jason Shao, Lindsay N Carpp, Andrew J Fiore-Gartland, David Benkeser, Yves Girerd-Chambaz, Edith Langevin, Carina Frago, Bruno Guy, Nicholas Jackson, Kien Duong Thi Hue, Cameron P Simmons, Paul T Edlefsen, Peter B Gilbert

Proceedings of the National Academy of Sciences of the United States of America 2018;115(36):E8378-E8387

Free Full Text

Abstract

Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine efficacy trial in Asia.

Li Qi, Yanqing Sun, Michal Juraska, Zoe Moodie, Craig A Magaret, Fei Heng, Lindsay N Carpp, Peter B Gilbert

Vaccine 2022;40(41):5912-5923

Free Full Text

Abstract

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.

Delia Yu, Suely Tuboi, Yanee Hutagalung, Ian Escudero, Pio Lopez, Charissa Borja-Tabora, Lulu Bravo, Felix Espinoza, Pope Kosalaraksa, Nicolas Folschweiller, Luis Rivera, Shibadas Biswal, Chukiat Sirivichayakul, Veerachai Watanaveeradej, LakKumar Fernando, Asvini D Fernando, Kleber Luz, Martina Rauscher, Olaf Zent, Inge LeFevre, Vianney Tricou, Derek Wallace, V Pujitha Wickramasinghe, Xavier Saez-Llorens, Luis Martinez Vargas, Maria Theresa Alera, Humberto Reynales, Reynaldo Dietze, Dulanie Gunasekera, Edson Duarte Moreira, Ana Lucia Oliveira, Eric Lloyd

The Lancet. Global health 2024;12(2):e257-e270

Free Full Text

Abstract

Dengue-associated hypokalemic paralysis: causal or incidental?

Hardeep Singh Malhotra, Ravindra Kumar Garg

Journal of the neurological sciences 2014;340(1-2):19-25

Full Text

Abstract

Human genetic determinants of dengue virus susceptibility.

Lark L Coffey, Eva Mertens, Anne-Claire Brehin, Maria Dolores Fernandez-Garcia, Ali Amara, Philippe Després, Anavaj Sakuntabhai

Microbes and infection 2009;11(2):143-56

Free Full Text

Abstract

Hit-to-Lead Short Peptides against Dengue Type 2 Envelope Protein: Computational and Experimental Investigations.

Norburhanuddin Johari Zaidi, Adib Afandi Abdullah, Choon Han Heh, Chun-Hung Lin, Rozana Othman, Abdullah Al Hadi Ahmad Fuaad

Molecules (Basel, Switzerland) 2022;27(10):3233

Free Full Text

Abstract

Dengue hemorrhagic fever and the kidney.

Prayong Vachvanichsanong, Usa Thisyakorn, Chule Thisyakorn

Archives of virology 2016;161(4):771-8

Full Text

Abstract

Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination.

Charissa Borja-Tabora, Hector Velásquez, Delia Yu, Edson Duarte Moreira, Asvini D Fernando, Pope Kosalaraksa, Felix Espinoza, Eduardo López-Medina, Lulu Bravo, Luis Rivera, Shibadas Biswal, Chukiat Sirivichayakul, Veerachai Watanaveeradej, Pujitha Wickramasinghe, Kleber Luz, Martina Rauscher, Mengya Liu, Inge LeFevre, Vianney Tricou, Derek Wallace, Astrid Borkowski, Xavier Saez-Llorens, Luis Martinez Vargas, Maria Theresa Alera, Humberto Reynales, Edith Johana Rodriguez-Arenales, Reynaldo Dietze, Lak Kumar Fernando, Dulanie Gunasekera, Rivaldo Venâncio da Cunha

The Journal of infectious diseases 2022;225(9):1521-1532

Free Full Text

Abstract

Dengue fever: natural management.

Muhammad Imran Qadir, Khizar Abbas, Madeha Tahir, Muhammad Irfan, Syeda Fiza Raza Bukhari, Bilal Ahmed, Muhammad Hanif, Akhtar Rasul, Muhammad Ali

Pakistan journal of pharmaceutical sciences 2015;28(2):647-55

Full Text

Abstract

Computational prediction of immunodominant antigenic regions & potential protective epitopes for dengue vaccination.

Karthikeyan Muthusamy, Krishnasamy Gopinath, Dharmalingam Nandhini

The Indian journal of medical research 2017;144(4):587-591

Free Full Text

Abstract

Results: 1 – 15 / 140

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Dengue""[mesh_terms]

E-Protein Protonation Titration-Induced Single-Particle Chemical Force Spectroscopy for Microscopic Understanding and pI Estimation of Infectious DENV.

Immunogenicity and safety of tetravalent dengue vaccines: a systematic review of clinical trials.

An overview of dengue viral infection circulating in Pakistan.

Liver involvement in dengue: A systematic review.

Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003).

Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials.

Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine efficacy trial in Asia.

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.

Dengue-associated hypokalemic paralysis: causal or incidental?

Human genetic determinants of dengue virus susceptibility.

Hit-to-Lead Short Peptides against Dengue Type 2 Envelope Protein: Computational and Experimental Investigations.

Dengue hemorrhagic fever and the kidney.

Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination.

Dengue fever: natural management.

Computational prediction of immunodominant antigenic regions & potential protective epitopes for dengue vaccination.

Results for
""Dengue""[mesh_terms]